172 related articles for article (PubMed ID: 9282327)
1. Reciprocal modulation between Sp1 and Egr-1.
Huang RP; Fan Y; Ni Z; Mercola D; Adamson ED
J Cell Biochem; 1997 Sep; 66(4):489-99. PubMed ID: 9282327
[TBL] [Abstract][Full Text] [Related]
2. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
Liu C; Calogero A; Ragona G; Adamson E; Mercola D
Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
[TBL] [Abstract][Full Text] [Related]
3. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants.
Silverman ES; Du J; De Sanctis GT; Rådmark O; Samuelsson B; Drazen JM; Collins T
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):316-23. PubMed ID: 9698605
[TBL] [Abstract][Full Text] [Related]
4. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
Skerka C; Decker EL; Zipfel PF
Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
[TBL] [Abstract][Full Text] [Related]
5. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
6. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells.
Nenoi M; Ichimura S; Mita K; Yukawa O; Cartwright IL
Cancer Res; 2001 Aug; 61(15):5885-94. PubMed ID: 11479230
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Egr-1-dependent gene expression by the C-terminal activation domain.
Gosslar U; Schmid RM; Holzmann B
Biochem Biophys Res Commun; 1999 Feb; 255(2):208-15. PubMed ID: 10049687
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: Crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1.
Mahapatra NR; Mahata M; Ghosh S; Gayen JR; O'Connor DT; Mahata SK
J Neurochem; 2006 Oct; 99(1):119-33. PubMed ID: 16987240
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal regulation of beta(1)-adrenergic receptor gene transcription by Sp1 and early growth response gene 1: induction of EGR-1 inhibits the expression of the beta(1)-adrenergic receptor gene.
Bahouth SW; Beauchamp MJ; Vu KN
Mol Pharmacol; 2002 Feb; 61(2):379-90. PubMed ID: 11809863
[TBL] [Abstract][Full Text] [Related]
11. Role of zinc-finger proteins Sp1 and zif268/egr-1 in transcriptional regulation of the human synaptobrevin II gene.
Petersohn D; Thiel G
Eur J Biochem; 1996 Aug; 239(3):827-34. PubMed ID: 8774732
[TBL] [Abstract][Full Text] [Related]
12. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
13. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter.
Zhang P; Tchou-Wong KM; Costa M
Cancer Res; 2007 Oct; 67(19):9125-33. PubMed ID: 17909017
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
[TBL] [Abstract][Full Text] [Related]
15. Sp1 interacts with the consensus sequence for Egr-1 gene product with a cellular factor(s) and activates the transcription through this element.
Kutoh E; Schwander J
Biochem Biophys Res Commun; 1993 Aug; 194(3):1475-82. PubMed ID: 8352806
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for cell-specific regulation of the NADPH-cytochrome P450 oxidoreductase gene.
O'Leary KA; Kasper CB
Arch Biochem Biophys; 2000 Jul; 379(1):97-108. PubMed ID: 10864447
[TBL] [Abstract][Full Text] [Related]
18. Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes.
Jin Y; Sheikh F; Detillieux KA; Cattini PA
Mol Pharmacol; 2000 May; 57(5):984-90. PubMed ID: 10779383
[TBL] [Abstract][Full Text] [Related]
19. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
